1) 5% glucose and sodium chloride injection
5%葡萄糖氯化钠注射液
1.
METHODS: The change of Pazufloxacin Mesylate for Injection in the appearance and the pH value within 12 h after mixing with fructose injection or 5% glucose and sodium chloride injection were investigated and the content of Pazufloxacin Mesylate was determined by HPLC.
方法:考察注射用甲磺酸帕珠沙星与果糖注射液、5%葡萄糖氯化钠注射液配伍后在12h内的外观及pH值变化,采用高效液相色谱法测定甲磺酸帕珠沙星的含量。
2) glucose and sodium chloride potassium chloride injection
葡萄糖氯化钠钾注射液
1.
Compatible stabilities of glucose and sodium chloride potassium chloride injection mixing with aciclovir and ganciclovir for injection;
葡萄糖氯化钠钾注射液与注射用阿昔洛韦、更昔洛韦配伍的稳定性
2.
OBJECTIVE To observe the stabilities of glucose and sodium chloride potassium chloride injection mixing with lincomycin,aminophylline,fluconazole,ornidazole respectively at 25 ℃.
目的研究在室温下葡萄糖氯化钠钾注射液分别与林可霉素、氨茶碱、氟康唑、奥硝唑配伍后的稳定性。
3) Polyglucose and sodium chloride injection
聚葡萄糖氯化钠注射液
5) polyglucose and sodium chlorid
缩合葡萄糖氯化钠注射液
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条